Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Fuji
McKesson
Express Scripts
UBS

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,207,143

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,207,143
Title:Methods of treating cancer and other conditions or disease states using LFMAU and LDT
Abstract: The present invention relates to the use of the compound according to formula (I), below for the treatment of tumors, cancer and hyperproliferative diseases, among other conditions or disease states: Where X is H or F; R.sup.1 and R.sup.2 are independently H, an acyl group, a C.sub.1-C.sub.20 alkyl or ether group, a phosphate, diphosphate, triphosphate or a phosphodiester group, a (A) or (B) group; Where Nu is a radical of a biologically active compound such as an anticancer, antiviral or antihyperproliferative compound such that an amino group or hydroxyl group from said biologically active agent forms a phosphate, phosphoramidate, carbonate or urethane group with the adjacent moiety; each R.sup.8 is independently H, or a C.sub.1-C.sub.20 alkyl or ether group, preferably a C.sub.1-C.sub.12 alkyl group; k is 0-12, preferably, 0-2; and pharmaceutically acceptable salts thereof. ##STR00001##
Inventor(s): Cheng; Yung-chi (Woodbridge, CT)
Assignee: Yale University (New Haven, CT)
Application Number:13/004,401
Patent Claims:see list of patent claims

Details for Patent 8,207,143

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Sign Up Yale University (New Haven, CT) ➤ Sign Up RX Orphan search
Spectrum Pharms ZEVALIN ibritumomab tiuxetan INJECTABLE; INJECTION 125019 001 2002-02-19 ➤ Sign Up Yale University (New Haven, CT) ➤ Sign Up RX Orphan search
Amgen ARANESP darbepoetin alfa VIAL; SUBCUTANEOUS 103951 010 2001-09-17 ➤ Sign Up Yale University (New Haven, CT) ➤ Sign Up RX search
Amgen ARANESP darbepoetin alfa VIAL; SUBCUTANEOUS 103951 009 2001-09-17 ➤ Sign Up Yale University (New Haven, CT) ➤ Sign Up RX search
Amgen ARANESP darbepoetin alfa VIAL; SUBCUTANEOUS 103951 008 2001-09-17 ➤ Sign Up Yale University (New Haven, CT) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Boehringer Ingelheim
Accenture
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.